Oncolytic Virus Disrupts Immune-Blocking Protein - NCI

Oncolytic Virus Disrupts Immune-Blocking Protein - NCI

4.6
(575)
Write Review
More
$ 17.99
Add to Cart
In stock
Description

Researchers have modified an oncolytic virus so that it blocks the protein TGF-beta, helping expose tumors to the immune system.

Oncolytic Parapoxvirus induces Gasdermin E-mediated pyroptosis and activates antitumor immunity

Cancers, Free Full-Text

Ann Hinck Facebook, Instagram & Twitter on PeekYou

Oncolytic viruses: a new class of immunotherapy drugs

Combining of Oncolytic Virotherapy and Other Immunotherapeutic Approaches in Cancer: A Powerful Functionalization Tactic - Zou - 2023 - Global Challenges - Wiley Online Library

Oncolytic viruses as a promising therapeutic strategy against the detrimental health impacts of air pollution: The case of glioblastoma multiforme - ScienceDirect

Oncolytic Viruses and Immune Checkpoint Inhibition: The Best of Both Worlds - ScienceDirect

Integrating oncolytic viruses in combination cancer immunotherapy

Design of an Interferon-Resistant Oncolytic HSV-1 Incorporating Redundant Safety Modalities for Improved Tolerability - ScienceDirect